Detalles de la búsqueda
1.
Respiratory Syncytial Virus Prefusion F Protein Vaccine Is Efficacious in Older Adults With Underlying Medical Conditions.
Clin Infect Dis
; 78(1): 202-209, 2024 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37698366
2.
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial.
J Infect Dis
; 227(6): 761-772, 2023 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35904987
3.
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials.
Lancet
; 397(10268): 39-50, 2021 01 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33308429
4.
Respiratory Syncytial Virus Disease Burden in Community-Dwelling and Long-Term Care Facility Older Adults in Europe and the United States: A Prospective Study.
Open Forum Infect Dis
; 10(4): ofad111, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37065988
Resultados
1 -
4
de 4
1
Próxima >
>>